Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Successful Treatment of a Severe Vision-Threatening Paradoxical Tuberculous Reaction with Infliximab: First Pediatric Use.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Williams & Wilkins Country of Publication: United States NLM ID: 8701858 Publication Model: Print Cited Medium: Internet ISSN: 1532-0987 (Electronic) Linking ISSN: 08913668 NLM ISO Abbreviation: Pediatr. Infect. Dis. J. Subsets: In Process; MEDLINE
    • Publication Information:
      Original Publication: [Baltimore, Md. : Williams & Wilkins, c1987-
    • Abstract:
      A 7-year-old girl with tuberculous (TB) meningitis developed optochiasmatic arachnoiditis, a vision-threatening paradoxical reaction, after starting TB treatment including adjunctive steroid therapy. She was treated with infliximab with complete recovery. This is the first report of the use of a tissue necrosis factor α inhibitor for the treatment of a severe paradoxical TB reaction in a child.
    • Publication Date:
      Date Created: 20200116 Latest Revision: 20200616
    • Publication Date:
      20201020
    • Accession Number:
      10.1097/INF.0000000000002578
    • Accession Number:
      31939874
  • Citations
    • ABNT:
      ABO, Y.-N. et al. Successful Treatment of a Severe Vision-Threatening Paradoxical Tuberculous Reaction with Infliximab: First Pediatric Use. The Pediatric infectious disease journal, [s. l.], v. 39, n. 4, p. e42–e45, 2020. DOI 10.1097/INF.0000000000002578. Disponível em: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdc&AN=31939874. Acesso em: 28 out. 2020.
    • AMA:
      Abo Y-N, Curtis N, Butters C, Rozen TH, Marais BJ, Gwee A. Successful Treatment of a Severe Vision-Threatening Paradoxical Tuberculous Reaction with Infliximab: First Pediatric Use. The Pediatric infectious disease journal. 2020;39(4):e42-e45. doi:10.1097/INF.0000000000002578
    • APA:
      Abo, Y.-N., Curtis, N., Butters, C., Rozen, T. H., Marais, B. J., & Gwee, A. (2020). Successful Treatment of a Severe Vision-Threatening Paradoxical Tuberculous Reaction with Infliximab: First Pediatric Use. The Pediatric Infectious Disease Journal, 39(4), e42–e45. https://doi.org/10.1097/INF.0000000000002578
    • Chicago/Turabian: Author-Date:
      Abo, Yara-Natalie, Nigel Curtis, Coen Butters, Thomas H Rozen, Ben J Marais, and Amanda Gwee. 2020. “Successful Treatment of a Severe Vision-Threatening Paradoxical Tuberculous Reaction with Infliximab: First Pediatric Use.” The Pediatric Infectious Disease Journal 39 (4): e42–45. doi:10.1097/INF.0000000000002578.
    • Harvard:
      Abo, Y.-N. et al. (2020) ‘Successful Treatment of a Severe Vision-Threatening Paradoxical Tuberculous Reaction with Infliximab: First Pediatric Use’, The Pediatric infectious disease journal, 39(4), pp. e42–e45. doi: 10.1097/INF.0000000000002578.
    • Harvard: Australian:
      Abo, Y-N, Curtis, N, Butters, C, Rozen, TH, Marais, BJ & Gwee, A 2020, ‘Successful Treatment of a Severe Vision-Threatening Paradoxical Tuberculous Reaction with Infliximab: First Pediatric Use’, The Pediatric infectious disease journal, vol. 39, no. 4, pp. e42–e45, viewed 28 October 2020, .
    • MLA:
      Abo, Yara-Natalie, et al. “Successful Treatment of a Severe Vision-Threatening Paradoxical Tuberculous Reaction with Infliximab: First Pediatric Use.” The Pediatric Infectious Disease Journal, vol. 39, no. 4, Apr. 2020, pp. e42–e45. EBSCOhost, doi:10.1097/INF.0000000000002578.
    • Chicago/Turabian: Humanities:
      Abo, Yara-Natalie, Nigel Curtis, Coen Butters, Thomas H Rozen, Ben J Marais, and Amanda Gwee. “Successful Treatment of a Severe Vision-Threatening Paradoxical Tuberculous Reaction with Infliximab: First Pediatric Use.” The Pediatric Infectious Disease Journal 39, no. 4 (April 2020): e42–45. doi:10.1097/INF.0000000000002578.
    • Vancouver/ICMJE:
      Abo Y-N, Curtis N, Butters C, Rozen TH, Marais BJ, Gwee A. Successful Treatment of a Severe Vision-Threatening Paradoxical Tuberculous Reaction with Infliximab: First Pediatric Use. The Pediatric infectious disease journal [Internet]. 2020 Apr [cited 2020 Oct 28];39(4):e42–5. Available from: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdc&AN=31939874